Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.0 EUR
127.92 M EUR
1.26 B EUR
30.07 M
About CONMED Corporation
Sector
Industry
CEO
Patrick Joseph Beyer
Website
Headquarters
Largo
Founded
1970
ISIN
US2074101013
FIGI
BBG000GQH1Z5
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CONMED Corporation stocks are traded under the ticker EC8.
We've gathered analysts' opinions on CONMED Corporation future price: according to them, EC8 price has a max estimate of 59.57 EUR and a min estimate of 49.93 EUR. Watch EC8 chart and read a more detailed CONMED Corporation stock forecast: see what analysts think of CONMED Corporation and suggest that you do with its stocks.
Yes, you can track CONMED Corporation financials in yearly and quarterly reports right on TradingView.
CONMED Corporation is going to release the next earnings report on Oct 22, 2025. Keep track of upcoming events with our Earnings Calendar.
EC8 earnings for the last quarter are 0.98 EUR per share, whereas the estimation was 0.95 EUR resulting in a 2.37% surprise. The estimated earnings for the next quarter are 0.89 EUR per share. See more details about CONMED Corporation earnings.
CONMED Corporation revenue for the last quarter amounts to 290.62 M EUR, despite the estimated figure of 287.23 M EUR. In the next quarter, revenue is expected to reach 283.88 M EUR.
EC8 net income for the last quarter is 18.18 M EUR, while the quarter before that showed 5.58 M EUR of net income which accounts for 225.92% change. Track more CONMED Corporation financial stats to get the full picture.
Yes, EC8 dividends are paid quarterly. The last dividend per share was 0.17 EUR. As of today, Dividend Yield (TTM)% is 1.60%. Tracking CONMED Corporation dividends might help you take more informed decisions.
CONMED Corporation dividend yield was 1.17% in 2024, and payout ratio reached 18.82%. The year before the numbers were 0.73% and 39.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 23, 2025, the company has 3.9 K employees. See our rating of the largest employees — is CONMED Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CONMED Corporation EBITDA is 172.22 M EUR, and current EBITDA margin is 16.54%. See more stats in CONMED Corporation financial statements.
Like other stocks, EC8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CONMED Corporation stock right from TradingView charts — choose your broker and connect to your account.